Categories
Stocks

AbbVie to Develop New COVID-19 Treatment

“Another big biopharmaceutical company has joined the crowd working to develop effective treatments for COVID-19. AbbVie (NYSE:ABBV) has partnered with Harbour BioMed, Utrecht University, and Erasmus Medical Center to develop 47D11, an antibody that blocks the SARS-CoV-2 coronavirus that causes COVID-19.”

Abbvie
Abbvie Stock Information

Full Motley Fool article here:

https://www.fool.com/investing/2020/06/05/abbvie-enters-the-race-to-develop-new-covid-19-tre.aspx

$ABBV Stock is currently priced at $93.85 cents.

Their current market cap is $165 billion dollars.

Abbvie stock 52 week high is and 52 $97 dollars and week low is $62 dollars.

If you are looking for a dividend, they currently have a payment of 5% which is a great yield for dividend investors.

$ABBV reported earnings of over $8 billion dollars in the quarter of March 2020.

ABBVIE Stock Analysis : A Value Investors Analysis of ABBVIE

ABBVIE Investor Relations Page:

https://investors.abbvie.com/investor-overview

Categories
Stocks

$IBM – IBM: New Decade, New Stock

IBM Stok
IBM Stock

Summary
IBM has been steadily losing revenues over the last decade. Despite this, the company offers an attractive dividend yield.

The new CEO is committed to increasing growth above all else.

Through the Red Hat acquisition and Cloud in general, IBM could achieve this and surprise investors.

https://seekingalpha.com/article/4349230-ibm-new-decade-new-stock

 

Categories
Stocks

Aurora Cannabis to acquire U.S. CBD brand Reliva for $40 million in stock

Aurora Cannabis
$ACB

Aurora Cannabis to acquire U.S. CBD brand Reliva for $40 million in stock
https://www.marketwatch.com/story/aurora-cannabis-to-acquire-us-cbd-brand-reliva-for-40-million-in-stock-2020-05-20?reflink=mw_share_email